Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2024

May 1, 2024

30786_dirs_2024-05-01_04464c5b-69e7-4ee0-9145-0c53d97fedf7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-05-03

Reporting Person: SCHWARTZ STEVEN D (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-05-03 Bio-Rad A Common Stock S 320 $463.86 Disposed 1498.0335 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad B Common Stock 25177 Direct
Bio-Rad A Common Stock 362146 Direct
Bio-Rad B Common Stock 12949 Indirect
Bio-Rad B Common Stock 4060054 Indirect

Footnotes

F1: Total reflects the number of shares beneficially owned by the insider as of the date of the report.

F2: The reporting person disclaims beneficial ownership of these shares.

F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.